National Health Investors, Inc. (NHI) P/E Ratio History
Historical price-to-earnings valuation from 1992 to 2026
Loading P/E history...
NHI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, National Health Investors, Inc. (NHI) trades at a price-to-earnings ratio of 24.2x, with a stock price of $73.09 and trailing twelve-month earnings per share of $3.05.
The current P/E is 18% below its 5-year average of 29.5x. Over the past five years, NHI's P/E has ranged from a low of 17.1x to a high of 58.8x, placing the current valuation at the 45th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.1x, NHI is roughly in line with its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.1x to 165.1x.
Relative to the broader market, NHI trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NHI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NHI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $14B | 23.8 | 1.02Best | +25% | |
| $5B | 31.8 | - | +19% | |
| $2B | 15.2Lowest | - | +24% | |
| $9B | 25.1 | 1.18 | +96% | |
| $94M | 115.3 | - | -95% | |
| $41B | 160.7 | - | +184%Best | |
| $150B | 154.2 | - | -11% | |
| $11B | 165.1 | - | -72% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NHI Historical P/E Data (1992–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $80.86 | $3.10 | 26.1x | +47% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $76.37 | $3.02 | 25.3x | +42% |
| FY2025 Q3 | $79.50 | $3.17 | 25.1x | +41% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $70.12 | $3.13 | 22.4x | +26% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $73.86 | $3.15 | 23.4x | +32% |
| FY2024 Q4 | $69.30 | $3.12 | 22.2x | +25% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $84.06 | $2.91 | 28.9x | +62% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $67.73 | $2.94 | 23.0x | +30% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $62.83 | $3.05 | 20.6x | +16% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $55.85 | $2.52 | 22.2x | +25% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $51.36 | $1.82 | 28.2x | +58% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $52.42 | $1.92 | 27.3x | +53% |
Average P/E for displayed period: 17.8x
See NHI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NHI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NHI vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonNHI — Frequently Asked Questions
Quick answers to the most common questions about buying NHI stock.
Is NHI stock overvalued or undervalued?
NHI trades at 24.2x P/E, near its 5-year average of 29.5x. The 45th percentile ranking places valuation within normal historical bounds.
How does NHI's valuation compare to peers?
National Health Investors, Inc. P/E of 24.2x compares to sector median of 24.1x. The premium reflects expected growth above peers.
What is NHI's PEG ratio?
NHI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1992-2026.